in a multi-centre double-blind cross-over trial using the double-placebo technique , 55 patients with rheumatoid arthritis were treated for 10 days for each trial drug with ketoprofen ( 200 mg/day ) and ibuprofen ( 1200 mg/day ) .
C0003873
rheumatoid arthritis
C0020740
ibuprofen